Metraipolis › archive › dc_edb1e7d09cd4

Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis — Europe PMC PMID:29802706

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/29802706
DOI
10.22034/apjcp.2018.19.5.1397
License (as archived)
solo-consultazione
Archived
2026-11-06T12:36:22.768Z
SHA-256 of the archived text
44aa9a3d6153ac28b6900acd7442f9d3ef39236b07415c73eb310d2b920e4eaf
Stable URL of this page
https://metraipolis.com/documento/dc_edb1e7d09cd4

How to cite

Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis — Europe PMC PMID:29802706 — Europe PMC (en), https://europepmc.org/article/MED/29802706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_edb1e7d09cd4 (Metraipolis archive dc_edb1e7d09cd4, sha256 44aa9a3d6153ac28b6900acd7442f9d3ef39236b07415c73eb310d2b920e4eaf)
BibTeX
@misc{dcedb1e7d09cd4,
  title = {Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis — Europe PMC PMID:29802706},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/29802706},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_edb1e7d09cd4; sha256 44aa9a3d6153ac28b6900acd7442f9d3ef39236b07415c73eb310d2b920e4eaf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29802706. Agents can read the archived copy with the MCP tool read_document.